Anita Kohli, MD
Assistant Professor
Department
Medicine (Phoenix)
Position
Assistant Professor
Publications
- Open forum infectious diseases
Ogbuagu Onyema, Goldman Jason D, Gottlieb Robert L, Singh Upinder, Shinkai Masaharu, Acloque Gerard, Fusco Dahlene, Gonzalez Erika, Kumar Princy N, Koullias Yiannis, Luetkemeyer Annie, Lichtman Amos, Mozaffarian Afsaneh, Hyland Robert H, Humeniuk Rita, Llewellyn Joe, Osinusi Anu, Duff Frank, Caro Luzelena, Etchevers Kim, Davies Santosh, Hedskog Charlotte, Chen Shuguang, Nadig Priyanka, Kohli Anita, P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study
12:Suppl 1 2025 - Journal of the Pediatric Infectious Diseases Society
Norton Thomas D, Roque-Guerrero Lilia, Ali Shazia, Turner Kenneth C, Hamilton Jennifer D, Thakur Mazhar, Ganguly Samit, Atmodjo Dominique, Hooper Andrea T, Hussein Mohamed, Subramaniam Danise, Chao Jesse, Waldron Alpana, Xiao Jing, Davis John D, Hughes Diana, Irvin Susan C, Pan Cynthia, Mylonakis Eleftherios, Geba Gregory P, Cox Edward, Kohli Anita, Herman Gary A, Braunstein Ned, Dakin Paula, Kowal Bari, Bhore Rafia, DiCioccio A Thomas, , Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in Pediatric Outpatients With COVID-19 2024 - Journal of hepatology
Dale Kelly, Kohli Anita, Nadeem Rida, Alkhouri Naim, WED-151 Routine cholestasis genetic testing in patients with intrahepatic cholestasis of pregnancy reveals high prevalence of genetic variants of bile acid transport defects
80, p. S709 - S710 2024 - Journal of hepatology
Yuen Man-Fung, Heo Jeong, Nahass Ronald G., Wong Grace Lai-Hung, Burda Tatiana, Bhamidimarri Kalyan Ram, Hu Tsung-Hui, Nguyen Tuan T., Chen Chi-Yi, Gordon Stuart C., Holmes Jacinta, Chuang Wan-Long, Kohli Anita, Alkhouri Naim, Lim Young-Suk, Eley Timothy, Gray Kevin, Thi Emily P., Medvedeva Elina, Ganchua Sharie C., Iott Christina, Eill Elizabeth, Espiritu Christine L., Sims Karen D., Anderson Mark, Fortney Tiffany, Cloherty Gavin, WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment
80, p. S809 - S810 2024 - The American journal of gastroenterology
Leff Phillip, Rida Nadeem, Dinner Brett, Ria Kundu, Naim Alkhouri, Kohli Anita, S3496 A Rare Case of Non-Cirrhotic Portal Hypertension Caused by Necrobiotic Xanthogranuloma
118:10S, p. S2296 - S2296 2023 - Open forum infectious diseases
Shapiro Adrienne E, Acloque Jude, Free Almena, Gonzalez-Rojas Yaneicy, Hussain Rubaba, Juarez Erick, Moya Jaynier, Parikh Naval, Pang Phillip S, Hong David K, Sager Jennifer E, Yeh Wendy W, Alexander Elizabeth L, Nader Ahmed, Gaffney Leah A, Kohli Anita, Inman David, Cebrik Deborah, Noormohamed Nadia, Wang Qianwen, Skingsley Andrew, Parra Sergio, Austin Daren, Peppercorn Amanda, Agostini Maria L, Chow Sophia, Mogalian Erik, Sarkis Elias, Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial 2023 - Journal of hepatology
Yuen Man-Fung, Heo Jeong, Nahass Ronald G, Wong Grace Lai-Hung, Burda Tatiana, Bhamidimarri Kalyan Ram, Nguyen Tuan, Lim Young-Suk, Medvedeva Elina, Hu Tsung-Hui, Chen Chi-Yi, Gordon Stuart C, Holmes Jacinta, Chuang Wan-Long, Kohli Anita, Alkhouri Naim, Gray Kevin, Thi Emily P., Eley Timothy, Sims Karen, LBP-38 - Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection
78, p. S125 - S125 2023 - Journal of hepatology
Alkhouri Naim, Topete Jesus, McCallum Meaghan, Blessing Kelly, Noureddin Mazen, Coste Angie, Kohli Anita, FRI-525 - The effects of a novel online app (Noom Weight) on weight loss and liver biomarkers in patients with NAFLD: a single arm proof-of-concept study
78, p. S828 - S828 2023 - Journal of hepatology
Alkhouri Naim, Leff Phillip, Nadeem Rida, Kohli Anita, Munteanu Mona, SAT-488 - LIVERFASt GP+ (GP+), a non-invasive blood testing for NAFLD staging, improves risk stratification of patients with indeterminate FIB-4 results
78, p. S711 - S711 2023 - Hepatology communications
Noureddin Mazen, Mena Edward, Vuppalanchi Raj, Samala Niharika, Wong Micaela, Pacheco Fabiana, Polanco Prido, Sakkal Celine, Antaramian Ani, Chang Devon, Noureddin Nabil, Alkhouri Naim, Kohli Anita, Harrison Stephen A. A., Gwarieh Samer, Truong Emily, Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+and 4 scores
7:5 2023 - Hepatology (Baltimore, Md.)
Chang Devon, Guindi Maha, Mena Edward A, Pacheco Fabiana, Wong Micaela, Todo Tsuyoshi T, Noureddin Mazen, Harrison Stephen, Noureddin Nabil, Ayoub Walid, Yang Ju Dong, Truong Emily, Kim Irene K, Kohli Anita, Alkhouri Naim, Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis
77:2, p. 546 - 557 2023 - Clinical gastroenterology and hepatology
Lawitz Eric J., Ruane Peter J., Kohli Anita, Harting Eliza, Ding Dora, Chuang Jen-Chieh, Huss Ryan S., Chung Chuhan, Myers Robert P., Loomba Rohit, Bhandari Bal Raj, Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
21:1, p. 143 - 152.e3 2023 - Journal of hepatology
Alkhouri Naim, Herring Robert, Kabler Heidi, Kayali Zeid, Hassanein Tarek, Kohli Anita, Huss Ryan S., Zhu Yanni, Billin Andrew N., Balendran Clare, Damgaard Lars Holm, Buchholtz Kristine, Kjaer Mette Skalshoi, Myers Robert P., Loomba Rohit, Noureddin Mazen, Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
77:3, p. 607 - 618 2022 - Journal of hepatology
Noureddin Mazen, Kohli Anita, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege, Caldwell Stephen, Goodman Zachary, Huss Ryan, Ma Lily, Ding Dora, Chuang Jay, Poulos John, Chung Chuhan, Myers Robert, Patel Keyur, Borg Brian, Ghalib Reem, Iyer Rajalakshmi, Younes Ziad H., Elkhashab Magdy, Hassanein Tarek, Ruane Peter, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Loomba Rohit, Alkhouri Naim, Kowdley Kris V., The MRI and AST (MAST) score is correlated with noninvasive and histologic markers of fibrosis in patients with advanced fibrosis due to NASH
77, p. S427 2022 - The lancet. Gastroenterology & hepatology
Harrison Stephen A., Leibowitz Mark, Khazanchi Arun, Sheikh Muhammad Y., Guy Cynthia D., Abdelmalek Manal F., Neff Guy, Gunn Nadege, Alkhouri Naim, Younes Ziad H., Bashir Mustafa R., Freilich Bradley, Kohli Anita, Rinella Mary E., Siddiqui Mohammad S., Kipnes Mark, Moussa Sam E., Bansal Meena, Baum Seth J., Thuluvath Paul J., Ling Lei, Lieu Hsiao D., Borg Brian, Ruane Peter J., Gottwald Mildred, Chang William, Khan Mujib, Chen Charles, Melchor-Khan Liza, DePaoli Alex M., Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
7:7, p. 603 - 616 2022 - Gastroenterology (New York, N.Y. 1943)
Leff Phillip, Polanco Prido, Chatha Yash, Garg Pranay, Lantz Kimber A., Raman Aria, Gupta Jia, Kahlon Nikhil S., Choudhri Sahil, Kohli Anita, Alkhouri Naim, Tu1311: EXTERNAL VALIDATION OF THE AGILE3+ SCORE AS A PREDICTOR OF ADVANCED FIBROSIS IN A COHORT OF U.S. ADULTS WITH BIOPSYPROVEN NAFLD
162:7, p. S-1271 2022 - The American journal of gastroenterology
Harrison Stephen A., Baum Seth J., Gunn Nadege T., Younes Ziad H., Kohli Anita, Patil Rashmee, Koziel Margaret J., Chakravarthy Manu V., Zhao Jeff, Chera Harinder, Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
116:12, p. 2399 - 2409 2021 - Nature communications
Harrison Stephen A., Gunn Nadege, Neff Guy W., Kohli Anita, Liu Liping, Flyer Abbey, Goldkind Lawrence, Di Bisceglie Adrian M., A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes
12:1, p. 5503 - 5503 2021 - American journal of preventive cardiology
Baum Seth J., Chakravarthy Manu V., Koziel Margaret J., Harrison Stephen A., Gunn Nadege T., Younes Ziad H., Kohli Anita, Zhao Jeff, Patil Rashmee, Fras Juan P., Hamill Michael, Daou Nadine, LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D
7, p. 100263 2021 - Hepatology communications
Younossi Zobair M., Stepanova Maria, Noureddin Mazen, Kowdley Kris V., Strasser Simone I., Kohli Anita, Ruane Peter, Shiffman Mitchell L., Huss Ryan S., Sheikh Aasim, Gunn Nadege, Caldwell Stephen H., Myers Robert P., Wai-Sun Wong Vincent, Loomba Rohit, Alkhouri Naim, Goodman Zachary, Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
5:7, p. 1201 - 1211 2021 - Diabetes (New York, N.Y.)
Baum SETH, Frias JUAN P., Hamill MICHAEL, Daou NADINE, Zhao JEFF, Chakravarthy MANU, Koziel MARGARET, Harrison STEPHEN A., Gunn NADEGE T., Younes ZIAD, Kohli ANITA, Patil RASHMEE, 752-P: LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D
70:Supplement_1 2021 - Hepatology (Baltimore, Md.)
Loomba Rohit, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege, Iyer Rajalakshmi, Ruane Peter, Shiffman Mitchell L., Strasser Simone, Wong Vincent Wai-Sun, Huss Ryan S., Ding Dora, Jia Catherine, Chuang Jen-Chieh, Chung Chuhan, Borg Brian B., Subramanian G. Mani, Myers Robert P., Patel Keyur, Ghalib Reem, Elkhashab Magdy, Kabler Heidi, Poulos John, Younes Ziad, Hassanein Tarek, Resnick Murray, Caldwell Stephen H., Goodman Zachary, Wapinski Ilan, Beck Andrew H., Kohli Anita, Noureddin Mazen, Kowdley Kris V., Alkhouri Naim, , Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
73:2, p. 625 - 643 2021 - Gastroenterology (New York, N.Y. 1943)
Harrison Stephen A., Frias Juan P., Younes Ziad, Trotter James F., Gunn Nadege T., Moussa Sam E., Kohli Anita, Nelson Kristin, Bashir Mustafa R., Neff Guy, Guy Cynthia D., Paredes Angelo H., Lieu Hsiao D., Gottwald Mildred, Chang William C.G., Yan Andrew Z., DePaoli Alex M., Ling Lei, Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
160:1, p. 219 - 231.e1 2021 - Hepatology (Baltimore, Md.)
Alkhouri Naim, Kohli Anita, Loomba Rohit, Harrison Stephen A, Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic
72:5, p. 1509 - 1513 2020 - The American journal of gastroenterology
Aggarwal Pankaj, Alkhouri Naim, Noureddin Mazen, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, S1025 The Effects of Age on the Accuracy of the FAST Score to Predict the Presence of NASH With Significant Fibrosis
115:1, p. S522 - S522 2020 - The American journal of gastroenterology
Aggarwal Pankaj, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Harrington Allison, Alkhouri Naim, S1024 Evaluation of the FAST Score in Patients With Nonalcoholic Fatty Liver Disease and High Liver Stiffness Measurements
115:1, p. S522 - S522 2020 - The American journal of gastroenterology
Aggarwal Pankaj, Harrington Allison, Singh Tamneet, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Alkhouri Naim, S3286 Identifying Patients With Metabolic Syndrome Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score
115:1, p. S1715 - S1715 2020 - The American journal of gastroenterology
Aggarwal Pankaj, Singh Tamneet, Harrington Allison, Cummings-John Oladuni, Kohli Anita, Noureddin Mazen, Alkhouri Naim, S1190 Identifying Patients With Type 2 Diabetes Mellitus Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis (NASH) Using the FAST Score
115:1, p. S595 - S595 2020 - Journal of hepatology
Harrison Stephen A., Younes Ziad H., Trotter James F., Gunn Nadege T., Moussa Sam, Kohli Anita, Nelson Kristen, Gottwald Mildred, Chang William, Yan Andrew, Depaoli Alex, Ling Lei, Lieu Hsiao, Bashir Mustafa, Neff Guy, Guy Cynthia, Paredes Angelo, Frias Juan, LBO01 - Positive topline results from a 24-week, randomized, double-blind, placebo-controlled, multicenter, phase 2 study of the FGF19 analogue aldafermin (NGM282) in patients with non-alcoholic steatohepatitis
73, p. S114 - S115 2020 - Journal of hepatology
Harrison Stephen A., Patil Rashmee, Koziel Margaret J., Chera Harinder, Zhao Jeff, Chakravarthy Manu V., Kohli Anita, Baum Seth J., Gunn Nadege T., Younes Ziad H., LBP01 - Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with non-alcoholic fatty liver disease (NAFLD) with and without type 2 diabetes (
73, p. S123 - S123 2020 - Journal of hepatology
Loomba Rohit, Noureddin Mazen, Kowdley Kris, Kohli Anita, Sheikh Aasim, Neff Guy, Bhandari Bal Raj, Gunn Nadege T., Caldwell Stephen, Goodman Zachary, Ding Dora, Wapinski Ilan, Resnick Murray, Beck Andrew, Jia Catherine, Huss Ryan, Chung Chuhan, Subramanian Mani, Ghalib Reem, Myers Robert, Patel Keyur, Borg Brian, Kabler Heidi, Poulos John, Younes Ziad H., Ruane Peter, Elkhashab Magdy, Hassanein Tarek, Iyer Rajalakshmi, Shiffman Mitchell, Strasser Simone, Wong Vincent Wai-Sun, Alkhouri Naim, LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
73, p. S116 - S117 2020 - Liver international
Pockros Paul J., Fuchs Michael, Freilich Bradley, Schiff Eugene, Kohli Anita, Lawitz Eric J., Hellstern Paul A., MacConell Leigh, Owens-Grillo Janet, Van Biene Courtney, Shringarpure Reshma, Shapiro David, Cohen David E., CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
39:11, p. 2082 - 2093 2019 - Open forum infectious diseases
Mera Jorge, Joshi Kartik, Thornton Karla, Box Terry, Scott John, Sedillo Miranda, Manch Richard, Deming Paulina, David Crystal, Essex Whitney, Kohli Anita, Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives
6:7, p. ofz128 - ofz128 2019 - Hepatology communications
Shrivastava Shikha, Bhatta Manasa, Ward Heley, Romani Sara, Lee Rebecca, Rosenthal Elana, Osinusi Anu, Kohli Anita, Masur Henry, Kottilil Shyam, Wilson Eleanor, Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
2:12, p. 1451 - 1466 2018 - Journal of Viral Hepatitis
Shrivastava S., Poonia B., Tang L., Osinusi A., Kohli Anita, Wilson E., Kottilil S., Augmentation of Hepatitis C Virus-Specific Immunity and Sustained Virologic Response
24:9, p. 742 - 749 2017 - Hepatology communications
Meissner Eric G., Kohli Anita, Higgins Jeanette, Lee Yu‐Jin, Prokunina Olga, Wu David, Orr Cody, Kottilil Shyam, Masur Henry, Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
1:7, p. 586 - 594 2017 - Scientific reports
Nguyen Thi Huyen Tram, Guedj Jérémie, Uprichard Susan L, Kohli Anita, Kottilil Shyam, Perelson Alan S, , The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?
7:1, p. 10233 - 10233 2017 - Journal of acquired immune deficiency syndromes (1999)
Wilson Eleanor, Lee Rebecca, Ward Haley, Howard Louisa, Rosenthal Elana, Shrivastava Shikha, Kohli Anita, Masur Henry, Kottilil Shyam, P-C8 Directly acting antiviral therapies have differential effects on cellular and soluble markers of inflammation in success-fully-treated HIV/HCV co-infected patients
74, p. 80 2017 - Journal of acquired immune deficiency syndromes (1999)
Rosenthal Elana, Bon Dimitra, Kattakuzhy Sarah, Tang Lydia, Hermann Eva, Kohli Anita, Kottilil Shyam, Wilson Eleanor, Masur Henry, P-C13 Impact of HIV status, HCV genotype, and number of DAAs on HCV viral kinetics in patients with HCV genotype 1 receiving DAA therapy
74, p. 82 2017 - World journal of hepatology
Tang Lydia Shuk Yee, Kottilil Shyam, Osinusi Anu, Kohli Anita, Kattakuzhy Sarah, Polis Michael, Nelson Amy, Masur Jack, Sims Zayani, Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
8:31, p. 1318 - 1326 2016 - Therapeutic advances in gastroenterology
Kohli Anita, Alshati Ali, Georgie Fawaz, Manch Richard, Gish Robert G., Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
9:6, p. 887 - 897 2016 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Kattakuzhy S., Gross C., Akoth E., McManus M., Emmanuel B., Shrivastava S., Tang L., . . . Kottilil, S., Kohli Anita, Wilson E., Price A., Sidharthan S., Sims Z., McLaughlin M., Silk R., Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease
62:4, p. 440 - 447 2016 - Clinics in Liver Disease
Joshi Kartik, Kohli Anita, Manch Richard, Gish Robert, Alcoholic Liver Disease: High Risk Or Low Risk for Developing Hepatocellular Carcinoma?
20:3, p. 563 - 580 2016 - Hepatology international
Thornton Karla, Deming Paulina, Manch Richard A, Moore Ann, Qualls Clifford, Scott John, Mera Jorge, Box Terry, Sedillo Miranda, Khaderi Saira, Arora Sanjeev, Kohli Anita, Gish Robert, Sussman Norman L, Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment
10:4, p. 624 - 631 2016 - Journal of Viral Hepatitis
Meissner E. G., Kohli Anita, Virtaneva K., Sturdevant D., Martens C., Porcella S. F., McHutchison J. G., Masur H., Kottilil S., Achieving Sustained Virologic Response After Interferon-Free Hepatitis C Virus Treatment Correlates with Hepatic Interferon Gene Expression Changes Independent of Cirrhosis
23:7, p. 496 - 505 2016 - Gastroenterology (New York, N.Y. 1943)
Ruane Peter J., Shiha Gamal, Abergel Armand, Asselah Tarik, Kohli Anita, Kottilil Shyam, Naggie Susanna, Doss Wahid, Esmat Gamal, Letterio Cathleen M., Kersey Kathryn, Hahambis Thomas A., Natha Macky, Kreter Bruce, Brainard Diana, Knox Steven, 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection
150:4, p. S1047 - S1048 2016 - Gastroenterology (New York, N.Y. 1943)
Flamm Steven, Modi Apurva A., Pungpapong Surakit, Leise Michael D., Aqel Bashar, Reddy K.R., Curry Michael, Brainard Diana, Llewellyn Joseph, Williams Laurie, Natha Macky, Kreter Bruce, Kohli Anita, Wyles David L., Lee Yoori, Su1423 Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/Sof) in Treatment-Experienced Cirrhotic Genotype 1 Patients With Chronic Hepatitis C (CHC): A Comparative Analysis of Gilead Sponsored Trials With 4 Real-World Cohorts (RWC)
150:4, p. S1095 - S1095 2016 - AIDS Research and Human Retroviruses
Townsend K., Meissner E. G., Sidharthan S., Sampson M., Remaley A. T., Tang L., Kohli Anita, Osinusi A., Masur H., Kottilil S., Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration
32:5, p. 456 - 462 2016 - Hepatology International
Petersen T., Townsend K., Gordon L. A., Sidharthan S., Osinusi A., Polis M. A., Masur H., Proschan M., Silk R., Kottilil S., Kohli Anita, Nelson A., Gross C., Calderon M., High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
10:2, p. 310 - 319 2016 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Wilson E. M., Kattakuzhy S., Sidharthan S., Sims Z., Tang L., McLaughlin M., Price A., Nelson A., Silk R., Subramanian G. M., . . . Kottilil, S., Gross C., Akoth E., Mo H., Kohli Anita, Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
62:3, p. 280 - 288 2016 - Clinical Advances in Hematology & Oncology
Kohli Anita, The Relationship between Hepatocellular Carcinoma and Hepatitis B and C Virus
14:2, p. 96 - 98 2016 - Expert review of anti-infective therapy
Nafisi Shirin, Roy Sabyasachi, Gish Robert, Manch Richard, Kohli Anita, Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?
14:1, p. 41 - 56 2016 - Journal of acquired immune deficiency syndromes (1999)
Kattakuzhy Sarah, Wilson Eleanor, Tang Lydia, Price Angie, Nelson Amy, Silk Rachel, Gross Chloe, Akoth Elizabeth, Kohli Anita, Osinusi Anu, Masur Henry, Kottilil Shyamasundaran, P-B4 Predictors of sustained viral response to 4–6 week duration therapy with Ledipasvir + Sofosbuvir + Gs-9451 +/− Gs-9669 in early and advanced fibrosis (Nih-Ihv synergy trial)
71:Supplement 1, p. 73 2016 - Journal of acquired immune deficiency syndromes (1999)
Wilson Eleanor, Mclaughlin Mary, Price Angie, Mo Hongmei, Osinusi Anu, Masur Henry, Kohli Anita, Kattakuzhy Sarah, Tang Lydia, Sims Zayani, P-B11 Retreatment of HCV GT-1 in patients who failed previous short course combination DAA therapy with 12 weeks of LDV/SOF is highly effective
71:Supplement 1, p. 77 2016 - AIDS (London, England)
Townsend K., Kohli Anita, Kottilil S., Nelson A., Seamon C., Gross C., Tang L., Osinusi A., Polis M. A., Petersen T., Gordon L. A., Masur H., Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir
30:2, p. 261 - 266 2016 - Annals of internal medicine
Kohli Anita, Sims Zayani, Silk Rachel, Gross Chloe, Akoth Elizabeth, Tang Lydia, Price Angie, Jolley Tim A., Emmanuel Benjamin, Proschan Michael, Osinusi Anuoluwapo, Teferi Gebeyehu, Chavez Jose, Abbott Stephen, Mo Hongmei, Polis Michael A., Wilson Eleanor, Masur Henry, Kottilil Shyam, McLaughlin Mary, Seamon Cassie, Meissner Eric G., Sidharthan Sreetha, Nelson Amy, Kattakuzhy Sarah, Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection
163:12, p. 899 2015 - The American journal of gastroenterology
Gill Kirat, Reynolds Justin, Kohli Anita, Moore Ann, Hepner Ashley, Gish Robert, Manch Richard, A Case of IgG4-Related Disease: A Unique Presentation of a Rare Entity
110, p. S109 - S110 2015 - The American journal of gastroenterology
Khosla Manraj, Dunatov Devin, Kohli Anita, Moore Ann, Hepner Ashley, Reynolds Justin, Manch Richard, Gish Robert, Recurrent Post-partum Jaundice: Rare Genetic Disorder With Novel Genetic Mutations Identified
110, p. S397 2015 - The American journal of gastroenterology
Gane Edward, Asselah Tarik, Kohli Anita, Mir Heshaam M., Natha Macky, Kersey Kathryn, Hyland Robert H., Pang Phil, McHutchison John G., Abergel Armand, Stedman Catherine A. M., Ledipasvir/Sofosbuvir With or Without Ribavirin for the Treatment of Patients With Genotype 2-6 Chronic HCV Infection: Summary Results From Four Phase II Studies
110, p. S870 - S871 2015 - Open forum infectious diseases
Hahn Katherine J., Kohli Anita, Sims Zayani, Kottilil Shyamasundaran, Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
2:3, p. ofv091 - ofv091 2015 - Clinical infectious diseases
Sidharthan Sreetha, Kohli Anita, Kottilil Shyam, Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials Reply
61:4, p. 667 - 668 2015 - The Lancet infectious diseases
Kohli Anita, Pang Phillip S., Osinusi Anu, Polis Michael A., Sugarman Kate, Rustgi Vinod, Masur Henry, Kottilil Shyam, Kapoor Rama, Sims Zayani, Nelson Amy, Sidharthan Sreetha, Lam Brian, Silk Rachel, Kotb Colleen, Gross Chloe, Teferi Gebeyehu, Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
15:9, p. 1049 - 1054 2015 - Clinical infectious diseases
Sidharthan Sreetha, Kohli Anita, Sims Zayani, Nelson Amy, Osinusi Anu, Masur Henry, Kottilil Shyam, Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy
60:12, p. 1743 - 1751 2015 - Journal of medical virology
Kohli Anita, Burbelo Peter, Barrett Lisa, Meissner Eric G., Santich Brian, Shaffer Ashton, Johl Jessica, Sidharthan Sreetha, Moir Susan, Funk Emily, Kottilil Shyam, Fauci Anthony S., Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse
87:4, p. 544 - 552 2015 - JAMA : the journal of the American Medical Association
Hogan John, Virologic response following combined ledipasvir and sofusbuvir administration in patients with HCV genotype 1 and HIV co-infection
313:12, p. 1232 2015 - The Lancet (British edition)
Kohli Anita, Petersen Tess, Townsend Kerry, Egerson D’Andrea, Kapoor Rama, Spurlin Emily, Teferi Gebeyehu, Kottilil Shyam, Subramanian G. Mani, Sneller Michael, Proschan Michael, Herrmann Eva, Kwan Richard, Osinusi Anuoluwapo, Sims Zayani, Nelson Amy, Meissner Eric G., Barrett Lisa L., Bon Dimitra, Marti Miriam M, Silk Rachel, Kotb Colleen, Gross Chloe, Jolley Tim A, Sidharthan Sreetha, Abbott Stephen, Talwani Rohit, Diaz Gabbie, Kleiner David E., Wood Brad J., Chavez Jose, Fauci Anthony S, Masur Henry, McHutchison John, Polis Michael A., Pang Phillip S., Symonds William T., Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study
385:9973, p. 1107 - 1113 2015 - JAMA : the journal of the American Medical Association
Kohli Anita, Kottilil Shyam, Assessment of outcomes of hepatitis C treatment--reply
312:23, p. 2571 - 2571 2014 - Open forum infectious diseases
Meissner Eric, Kohli Anita, Nelson Amy, Sims Zayani, Mchutchison John G., Masur Henry, Kottilil Shyam, LB-4Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens
1:suppl_1, p. S67 - S67 2014 - Annals of internal medicine
Osinusi Anu, Pang Phillip S., Subramanian G. Mani, McHutchison John G., Meissner Eric G., Silk Rachel, Townsend Kerry, Kohli Anita, Marti Miriam M., Nelson Amy, Zhang Xiaozhen, Fauci Anthony S., Masur Henry, Kottilil Shyam, Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse An Open-Label Pilot Study
161:9, p. 634 - U126 2014 - SpringerPlus
Kohli Anita, Murphy Allison A, Agarwal Chirdeep, Shivakumar Bhavana, Kottilil Shyam, Polis Michael A, Desai Srinivas, Subramanian G Mani, Midha Vandana, Goyal Omesh, Sood Ajit, Shah Samir, HCC surveillance results in earlier HCC detection: results from an Indian cohort
3:1, p. 1 - 5 2014 - JAMA : the journal of the American Medical Association
Kohli Anita, Kottilil Shyam, Sherman Amy, Shaffer Ashton, Treatment of Hepatitis C A Systematic Review
312:6, p. 631 - 640 2014 - AIDS research and human retroviruses
Shaffer Ashton, Hubbard Jon J., Townsend Kerry, Kottilil Shyam, Polis Michael A., Masur Henry, Kohli Anita, Short Communication: Serum-Based Assay Accurately Detects Single Nucleotide Polymorphisms of IL28B and SOCS3 in HIV/Hepatitis C Virus-Coinfected Subjects
30:8, p. 792 - 795 2014 - AIDS research and human retroviruses
Funk Emily K., Shaffer Ashton, Shivakumar Bhavana, Sneller Michael, Nelson Amy, Kwan Richard, Kottilil Shyam, Kohli Anita, Heytens Laura, Polis Michael A., Masur Henry, Short Communication: Interferon/Ribavirin Treatment for HCV Is Associated with the Development of Hypophosphatemia in HIV/Hepatitis C Virus-Coinfected Patients
29:9, p. 1190 - 1194 2013 - JAMA : the journal of the American Medical Association
Osinusi Anuoluwapo, Nelson Amy, Sneller Michael, Kwan Richard, Teferi Geb, Talwani Rohit, Meissner Eric G., Heytens Laura, Herrmann Eva, Shivakumar Bhavana, Gu Wenjuan, Lee Yu-Jin, Bon Dimitra, Wroblewski Susan, Kohli Anita, Barrett Lisa, Proschan Michael, Silk Rachel, Kotb Colleen, Fishbein Dawn, Kleiner David, Dewar Robin, Highbarger Helene, Zhang Xiao, Wood Brad J., McHutchison John, Chavez Jose, Symonds William T., Subramanian Mani, Polis Michael A., Fauci Anthony S., Masur Henry, Kottilil Shyamasundaran, Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial
310:8, p. 804 - 811 2013 - AIDS research and human retroviruses
Sherman Amy C., Trehanpati Nirupama, Daucher Marybeth, Davey Richard T., Masur Henry, Sarin Shiv Kumar, Kottilil Shyam, Kohli Anita, Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir
29:4, p. 665 - 672 2013 - Journal of acquired immune deficiency syndromes (1999)
Sidique Nadeera, Polis Michael A., Masur Henry, Kottilil Shyam, Kohli Anita, Shivakumar Bhavana, Migueles Stephen, Subramanian G. Mani, Naggie Susanna, HIV/HCV-Coinfected Natural Viral Suppressors Have Better Virologic Responses to PEG-IFN and Ribavirin Than ARV-Treated HIV/HCV Patients
58:2, p. E38 - E40 2011 - The American journal of tropical medicine and hygiene
Houpt Eric R, Bushen Oluma Y, Shao John F, Sam Noel E, Kohli Anita, Asgharpour Amon, NG Cherie T, Calfee David P, Guerrant Richard L, Maro Venance, OLE-NGUYAINE Sendui, Short report : Asymptomatic Cryptosporidium hominis infection among human immundeficiency virus-infected patients in tanzania
73:3, p. 520 - 522 2005